Guanethidine was administered in a single intravenous infusion to supine hypertensive and normotensive subjects. Hemodynamic changes during the transient pressor phase were consistent with catechol amine effect. The later hypotensive effect occurred only in the hypertensive subjects and was usually associated with a slight decrease in cardiac output in patients without cardiac decompensation and a slight increase in output in those with congestive heart failure. Total peripheral resistance decreased although there was an increase in splanchnic vascular resistance and a decrease in the percentage of the cardiac output perfusing the hepatic-portal bed.
Tests of sympathetic nervous system activity revealed that, although the Valsalva "overshoot" usually was blocked, complete inhibition of digital vasoconstrictor reflexes did not always occur and vascular responsiveness to tyramine and ephedrine was not diminished up to six hours following intravenous guanethidine. Tyramine responses were also demonstrated in a group of patients on effective long-term oral therapy with guanethidine.
These studies suggest that guanethidine has unique hemodynamic effects not necessarily shared by ganglionic blocking agents, bretylium tosylate, or reserpine. Catechol amine depletion probably is not important in the mechanism of the antihypertensive and sympathetic inhibitory actions in man, and the possibility of an additional non-adrenergic effect is considered.
The mechanism of the diastolic pressure elevation occurring during left stellate ganglion stimulation was investigated. The cardiac output rose considerably, the heart rate remained essentially unchanged, and the total peripheral resistance fell moderately. The diastolic rise appeared to be due to increased blood flow rather than to any active changes in resistance vessels.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.